Table 1.
Clinical characteristics of chronic lymphocytic leukemia (CLL) patients
| Patients n (%) | |
|---|---|
| Total | 247 |
| Sex | |
| Male | 173 (70.0) |
| Female | 74 (30.0) |
| Race | |
| Asian | 1 (0.4) |
| Black | 11 (4.5) |
| Hispanic | 7 (2.8) |
| White | 228 (92.3) |
| Rai Stage | |
| Low (0–2) | 196 (79.4) |
| High (3–4) | 51 (26.0) |
| Döhner Classification | |
| del13q | 90 (36.4) |
| +12 | 37 (15.0) |
| FISH normal | 73 (29.6) |
| del11q | 34 (13.8) |
| del17p | 13 (5.3) |
| IGHV Mutation Status | |
| Mutated | 106 (43.1) |
| Unmutated | 140 (56.9) |
| Treatment Status | |
| Never treated | 20 (8.1) |
| Treated with FCR | 227 (91.9) |
| Age at Diagnosis | Years |
| Minimum | 26.74 |
| Median | 55.87 |
| Maximum | 82.41 |
Selected clinical and routine laboratory data, somatic mutation status, and common recurrent cytogenetic abnormalities collected at time of diagnosis on 247 treatment-naïve patients diagnosed with CLL and obtained by chart review.